Physician profile
Christopher Weiss
NPI 1538189568
$1,508.66
in general payments reported to CMS, 2019-2025
18 companies · $207 in 2025
The $207 reported for 2025 was more than what 75% of Adolescent Medicine (Pediatrics) providers received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $325 · 2020: $199 · 2021: $206 · 2022: $157 · 2023: $184 · 2024: $230 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $621.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $291.47 | 2019-2023 | Auvi-Q |
| Sanofi Pasteur INC. | $219.36 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $211.44 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Glaxosmithkline, LLC. | $184.93 | 2019-2025 | Bexsero, Penmenvy, Pediarix |
| Becton, Dickinson and Company | $125.00 | 2019 | |
| Cranial Technologies, INC | $118.68 | 2020-2025 | Doc Band |
| Corium, LLC | $83.03 | 2022-2025 | Azstarys |
| Seqirus USA INC | $80.41 | 2022-2025 | Flucelvax, Flucelvax Quadrivalent |
| Astrazeneca Pharmaceuticals Lp | $35.14 | 2023-2024 | Flumist Quadrivalent |
| Dermira, INC. | $28.03 | 2020 | |
| Pfizer INC. | $27.48 | 2023-2024 | |
| Alk-Abello, INC | $17.86 | 2025 | Neffy |
| Alexion Pharmaceuticals, INC. | $16.37 | 2024 | Strensiq |
| Ars Pharmaceuticals Operations, INC. | $15.51 | 2025 | Neffy |
| Biomarin Pharmaceutical INC. | $14.99 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $14.60 | 2019 | |
| Aytu Biopharma, INC. | $12.50 | 2020 | |
| Ironshore Pharmaceuticals INC. | $11.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.